anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
OXYGEN, COMPRESSED USP UN 1072

D15 

Analgesic Services, Inc.

Sacramento, CA 95834

916-928-1068

ASI-01 OXYGEN 2 

WARNING: For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, Rx only. Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effect on oxygen content of arterial blood, may be harmful. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment. DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. Do not handle until all safety precautions have been read and understood. Keep and store away from clothing and other combustible materials. Keep valves and fittings free from grease and oil. Use and store only outdoors or in a well-ventilated place. In case of fire: Stop leak if safe to do so. Use a backflow preventive device in the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. Open valve slowly. Close valve after each use and when empty. Protect from sunlight when ambient temperature exceeds 52°C (125° F). Read and follow the Safety Data Sheet (SDS) before use. CAS 7782-44-7 DO NOT REMOVE THIS PRODUCT LABEL.

LOT # NET CONTENTS:
The invention discloses a mistura with effects of resolving hard mass and promoting lactation and a preparation method thereof, belonging to the field of traditional Chinese medicine. The composition is used for treating postpartum hypogalactia and breast milk silting-up and prepared by the following raw materials according to parts by weight: 30 parts of membranous milkvetch root, 15 parts of Chinese angelica, 15 parts of largehead atractylodes rhizome, 10 parts of beautiful sweetgum fruit, 10 parts of Chinese thorowax root, 6 parts of bitter orange (stir-fried, broken), 6 parts of pangolin scales, 10 parts of cowherb seed, 10 parts of uniflower swisscentaury root, 6 parts of Szechuan lovage rhizome, 15 parts of pilose Asiabell root, 10 parts of akebia stem, 10 parts of liquoric root and 600 parts of front pig trotters, the front pig trotters are stewed, then soup is used for decoction, and the mistura is prepared by concentration, bottling and disinfection. The invention can also make the addition and the subtraction based on the basic formula according to the symptoms. The mistura has low price, simple operation, convenient administration and no toxic side effects. The mistura can be made by patients, the cure rate for a variety of lack of milk, rare breast milk and breast duct blockage is 98.2 percent and the total effective rate is 100 percent. Compared with the other drugs at present, the effect is extremely significant.
PURPOSE: East Asian individuals have a lower risk of thromboembolic events while potentially carrying a higher risk of bleeding events compared with non-Asian individuals. The aim of the present analysis was to investigate the effectiveness and safety of the de-escalation of antiplatelet therapy compared with standard dual antiplatelet therapy (DAPT) in East Asian patients undergoing percutaneous coronary intervention (PCI).
METHODS: Randomized controlled trials comparing de-escalation with DAPT in patients with acute coronary syndrome (ACS) were retrieved from electronic databases from their inception until March 2022. Outcomes included major adverse cardiovascular events (MACE), ischemic events, major bleeding, minor bleeding, and any bleeding. Subgroup analyses based on treatment strategy were conducted. Statistical analysis was performed by using Review Manager version 5.4.
FINDINGS: Eight randomized controlled trials from 539 potentially relevant publications with a total of 15,744 East Asian patients were included. Pooled data from these studies found a significantly lower MACE (0.82; 95% CI, 0.69-0.98) and major bleeding event (0.62; 95% CI, 0.46-0.82) in de-escalation than standard-DAPT without heterogeneity. Subgroup analysis was divided into DAPT followed by P2Y12 inhibitor monotherapy and a reducing dose of P2Y12 inhibitors. DAPT followed by P2Y12 inhibitor monotherapy had a 48% lower incidence of major bleeding events than standard DAPT (0.52; 95% CI, 0.27-1.00); there was no significant difference in major bleeding (0.99; 95% CI, 0.55-1.76) between the reducing dose of P2Y12 inhibitors and standard DAPT.
IMPLICATIONS: De-escalation is a promising and potentially optimal antiplatelet therapy for patients from East Asia with PCI. DAPT followed by P2Y12 inhibitor monotherapy might be a safer and equally effective approach compared with standard DAPT in East Asian patients with PCI. PROSPERO identifier: CRD42022319983.
1425810 Combatting helminthic infestation BAYER AG 24 June 1974 [22 June 1973 13 Dec 1973] 27905/74 Heading A5B Helminthic infestation is combatted in a non-human animal by applying a liquid composition comprising D, L or L-2, 3, 5, 6-tetrahydro-6-phenyl-imidazo-(2, 1-b) thiazole (tetramisole and levamisole respectively) or an acid addition salt thereof e.g. a hydrochloride, as an active ingredient and a liquid diluent to the external skin of the animal. The composition may be sprayed or paired onto the animal. The composition may be in the form of a solution, suspension or emulsion containing conventional excipients e.g. propellants. The compositions may also comprise at least one other anthelmintic ingredient.
BACKGROUND: Presacral tumors are a rare entity typically treated with an open surgical approach. A limited number of minimally invasive resections have been described. The aim of the study is to evaluate the safety and efficacy of roboticresection of presacral tumors.
METHODS: This is a retrospective single system analysis, conducted at a quaternary referral academic healthcare system, and included all patients who underwent a robotic excision of a presacral tumor between 2015 and 2023. Outcomes of interest were operative time, estimated blood loss, complications, length of stay, margin status, and recurrence rates.
RESULTS: Sixteen patients (11 females and 5 males) were included. The median age of the cohort was 51 years (range 25-69 years). The median operative time was 197 min (range 98-802 min). The median estimated blood loss was 40 ml, ranging from 0 to 1800 ml, with one patient experiencing conversion to open surgery after uncontrolled hemorrhage. Urinary retention was the only postoperative complication that occurred in three patients (19%) and was solved within 30 days in all cases. The median length of stay was one day (range 1-6 days). The median follow-up was 6.7 months (range 1-110 months). All tumors were excised with appropriate margins, but one benign and one malignant tumor recurred (12.5%). Ten tumors were classified as congenital (one was malignant), two were mesenchymal (both malignant), and five were miscellaneous (one malignant).
CONCLUSIONS: Robotic resection of select presacral pathology is feasible and safe. Further studies must be conducted to determine complication rates, outcomes, and long-term safety profiles.
OBJECTIVE: Levator avulsion is a major etiological factor of pelvic organ prolapse (POP) and is primarily diagnosed on tomographic axial plane imaging. Two-dimensional imaging can also image the levator. The objective was to test reproducibility and validity of coronal plane assessment for diagnosis of levator trauma by assessing the coronal plane obtained on tomographic ultrasound imaging.
METHODS: A retrospective study of women who had undergone an interview, POPQ and four-dimensional translabial ultrasound at a tertiary urogynecological unit. Post-processing of archived volume data was performed for assessment; and levator muscle area and estimate of remnant muscle mass in the coronal plane. Interobserver reproducibility of the latter two measures and associations between various measures of levator trauma and POP were tested.
RESULTS: Interobserver agreement was good for percentage estimates (ICC 0.743), but fair for area measurements (ICC 0.482). Six hundred and twenty four women were seen, 468 (75%) had significant clinical prolapse. Full levator avulsions were diagnosed in 137 (22%). Mean TTS was 2.7 (range 0-12). On coronal plane assessment average muscle area was 1.47 (SD 0.76) cm2 and 1.55 (SD 0.74) cm2 on the right and left, respectively (P = .005). It was 76% and 79% for average estimates of muscle mass (P = .021). Both measures were strongly associated with POP; however, they were not superior to TTS in predicting POP.
CONCLUSION: Coronal plane assessment in volume data is reproducible and valid for evaluation of levator trauma. Muscle mass estimate may be a better measure than muscle area.
Evaluation of a health condition includes obtaining a correlation between dietary habits and health issues of a plurality of reference users. The correlation is determined based on reference patterns. Each of the reference patterns indicates temporal characteristics of at least one dietary habit and at least one health issue of a reference user of the plurality of reference users. A target pattern of a target user is determined at least in part based on a profile for the target user. The target pattern at least indicates temporal characteristics of at least one dietary habit of the target user. An evaluation of a health condition of the target user is generated based on the target pattern and the correlation.
Forty-five participants on the waitlist for a TKA will be recruited from Concordia Hospital Hip and Knee Institute - a facility that performs 800 TKA's per year. Participants will be divided into two groups: the pre-operative MBSR group (30 participants, divided into two MBSR groups), and the treatment-as-usual (TAU;15 participants). The individuals in the pre-operative MBSR group will receive a pre-operative 8-week community-based MBSR course taught by a certified instructor, which includes group classes lasting 2.5 hours a week, 45-minutes of home practice 6 days per week, a 1-hour orientation session at the beginning, and a full-day silent retreat at the end. During the orientation, participants will complete the study measures for this study. Two weeks prior to the surgery at the pre-anesthesia clinic, all patients will receive another set of short self-reported questionnaires. All patients will subsequently receive post-operative questionnaires at the following regularly scheduled post-operative appointments: 6-8 weeks after surgery, and at 6 month and 1 year follow-ups. Clinic personnel, who are blinded to assignment, will administer these measures with all other regularly distributed clinical measures. Clinic personnel will also review the chart to inform researchers as to what physical condition contributed to the need for a TKA. The TAU group will have the opportunity to enroll in an MBSR course following the completion of the study (after approximately 1 year), at no cost.
PURPOSE:To obtain the titled safe antibody capable of inhibiting effectively periodontitis, by isolating an antigen from pili of a microorganism of the genus Actinomyces, etc. having the ability to induce the periodontitis in the oral cavity, immunizing a mammal with the above-mentioned antigen, and collecting the produced corresponding antibody. CONSTITUTION:An antigen is isolated from pile of a microorganism, e.g. the genus Actinomyces or Bacteroides, having the ability to induce or wosen periodontitis and the pili on the surfaces of cells is isolated, and a mammal is immunized with the above-mentioned antigen to collect the corresponding antibody produced in the body and give the titled antibody. In particular, Actinomyces viscous variant strian K-TL + (FERM-P No.411) and Bacteroides gingivalis strain K-Bg-ml (FERM-P No.410) are advantageous to a raw material for producing the antibody. The above-mentioned antibody can be easily and effectively administered as a noncarious composition, e.g. a dentifrice or candy, by the presence of a cartier or excipient together therewith.
All participants will receive posaconazole 300 mg intravenous (IV) infusion twice on Day 1 followed by 300 mg IV infusion once daily on Days 2 to 10 (±1). At the discretion of the investigator, participants will received posaconazole 300 mg IV infusion once daily or 200 mg oral suspension three times daily for up to 18 additional days.
An absorbent article having a skin care composition is disclosed.     The absorbent article has a body surface and a garment surface. The absorbent article comprises a topsheet disposed at the body surface, a backsheet disposed at the garment surface, and an absorbent core disposed therebetween. At least a portion of the absorbent article is provided with a skin care composition. The absorbent article has a preferential acquisition zone and a skin care zone. The preferential acquisition zone covers at least a portion of the vulva of the wearer when the absorbent article is applied on the wearer's body. The skin care zone is provided with the skin care composition of greater basis weight than the preferential acquisition zone.
Abdominal hernia mesh is a common product which is used for prevention of abdominal adhesion and repairing abdominal wall defect. Currently, designing and preparing a novel bio-mesh material with prevention of adhesion, promoting repair and good biocompatibility simultaneously remain a great bottleneck. In this study, a novel siloxane-modified bacterial cellulose (BC) was designed and fabricated by chemical vapor deposition silylation, then the effects of different alkyl chains length of siloxane on surface properties and cell behaviors were explored. The effect of preventing of abdominal adhesion and repairing abdominal wall defect in rats with the siloxane-modified BC was evaluated. As the grafted alkyl chains become longer, the surface of the siloxane-modified BC can be transformed from super hydrophilic to hydrophobic. In vivo results showed that BC-C16 had good long-term anti-adhesion effect, good tissue adaptability and histocompatibility, which is expected to be used as a new anti-adhesion hernia repair material in clinic.
In order to provide care, social interaction, and health education, an educational protocol was conducted. This protocol consisted in interactive presentations of 60 minutes, twice a month for 14 weeks, totaling 7 meetings. The topics addressed pathophysiology of osteoarthritis, and American College of Rheumatology (ACR) recommendations on nutrition, posture, and lifestyle.
OBJECTIVE: The objective of this study was to develop a deep learning-and-radiomics-based ultrasound nomogram for the evaluation of axillary lymph node (ALN) metastasis risk in breast cancer patients ≥ 75 years.
METHODS: The study enrolled breast cancer patients ≥ 75 years who underwent either sentinel lymph node biopsy or ALN dissection at Fudan University Shanghai Cancer Center. DenseNet-201 was employed as the base model, and it was trained using the Adam optimizer and cross-entropy loss function to extract deep learning (DL) features from ultrasound images. Additionally, radiomics features were extracted from ultrasound images utilizing the Pyradiomics tool, and a Rad-Score (RS) was calculated employing the Lasso regression algorithm. A stepwise multivariable logistic regression analysis was conducted in the training set to establish a prediction model for lymph node metastasis, which was subsequently validated in the validation set. Evaluation metrics included area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1-score. The calibration of the model's performance and its clinical prediction accuracy were assessed using calibration curves and decision curves respectively. Furthermore, integrated discrimination improvement and net reclassification improvement were utilized to quantify enhancements in RS.
RESULTS: Histological grade, axillary ultrasound, and RS were identified as independent risk factors for predicting lymph node metastasis. The integration of the RS into the clinical prediction model significantly improved its predictive performance, with an AUC of 0.937 in the training set, surpassing both the clinical model and the RS model alone. In the validation set, the integrated model also outperformed other models with AUCs of 0.906, 0.744, and 0.890 for the integrated model, clinical model, and RS model respectively. Experimental results demonstrated that this study's integrated prediction model could enhance both accuracy and generalizability.
CONCLUSION: The DL and radiomics-based model exhibited remarkable accuracy and reliability in predicting ALN status among breast cancer patients ≥ 75 years, thereby contributing to the enhancement of personalized treatment strategies' efficacy and improvement of patients' quality of life.
Patients attend focus groups to help develop patient portal and navigation program. Patients use in-person navigation program. Patients also complete data collection and surveys over 15 minutes via web portal at baseline, 3 months, and 6 months and user experience survey at end of program participation.
The waitlist control group will be under usual care for the first 8 weeks. Then, they will start intervention after the 8 week, and receive two additional outcome assessments.
The invention relates to a pure traditional Chinese medicine preparation (Jiang Ya Ling) used for rapidly reducing blood pressure. For solving the problems of the inconvenience for decocting medicines every day and a swallowing difficulty of a bitter decoction, the invention provides a Chinese patent medicine preparation with functions of blood circulation activating, stasis removing, and blood sugar reducing. The Chinese patent medicine preparation is convenient to take. The medicine is prepared from 23 natural traditional Chinese medicines of red ochre, sea-ear shell, raw oyster, achyranthes bidentata, tuber fleeceflower root, hawthorn fruit, common selfheal spike, tuber fleeceflower stem and leaf, sharpleaf uncaria stem with ho-oks, Chinese taxillus herb, obtuseleaf senna seed, asiatic plantain herb, figwort, rehmannia dride rhizome, peony tree root bark, lumbricus, ligusticum, Szechwan lovage rhizome, safflower, frankincense, myrrh, rosewood heart wood, and rhubarb. Since the year 2008 to the year 2012, the medicine components are used for treating more than 600 patients of combined hypertension and hyperlipemia of various types, stages, and ages, among which 50 patients are closely observed and take the medicine continuously for 3-6 months. An effective rate and a completely normal rate of blood pressure reducing and blood fat reducing are 100%.
The OTO device is a wearable device that utilizes multiple methods of electrophysiology to identify the impact of stress on humans. The device consists of the OTO sensor, a belt with two electrode pads worn around the chest, one electrode placed on the thenar of the dominant hand and one electrode placed on the forehead; the sensor pairs with the OTO App via Bluetooth. It tracks 54 physiological properties including temperature, HRV, amplitude frequency analysis (AFA) of ECG and DC potential. This data is analyzed by the proprietary OTO Expert System which creates the overall conclusions on levels of stress, functional reserves, adaptive capacity and level of readiness to additional stressors.

Physiological data will be collected from the study participant using the OTO device for the duration of one IVF and frozen embryo transfer (FET) cycle. Study participants will complete questionnaires online related to perceived stress at the beginning and the end of study participation. Study participant's IVF cycle treatment and outcome data will be collected and analyzed in conjunction with the physiological data collected with the OTO device.
The objective of this study is to evaluate whether the administration by inhalation of ozone plasma favorably modifies lung function and inflammatory parameters in patients with pulmonary sequelae associated with coronavirus 19 infection (SARS-COV-2). We will conduct an open-ended, uncontrolled clinical trial in 35 male and female patients, between 25-80 years of age with previous confirmed diagnosis of COVID-19 infection with negative nasopharyngeal polymerase chain reaction assay (PCR) test and without active disease, patients will also continue with their usual treatment. Clinical findings and laboratory and cabinet tests include a basal and 14-day metabolic and inflammatory profile, body weight, body mass index (BMI) and blood pressure will be determined during the initial and final visit, as well as respiratory parameters by pulmonary function tests (spirometry, TLCo) and performing the 6 min walk test in endless band with pre- and post-walk oximetry measurements at the beginning and end of the study. Adverse events to treatment will be documented. Statistical analysis: Mann-Whitney U test and Wilcoxon exact test. A p \<0.05 shall be considered statistically significant.
PURPOSE:To obtain the titled capsules, obtained by adding a specific alkyl 2-cyanoacrylate to a water-in-oil type emulsion, and polymerizing the above- mentioned acrylate in the interface between the disperse phase and the dispersion medium to cover the disperse phase, and capable of adjusting the releasing property. CONSTITUTION:A mircoencapsulated pharmaceutical obtained by adding an alkyl 2-cyanoacrylate having a 1-8C alkyl group to a water-in-oil type emulsion containing a suspension of a chemical, e.g. a carcinostatic agent, e.g. mitomycin C or 5-fluorouracil, or an antibiotic substance, in an aqueous solution of a biocompatible high polymer, e.g. albumin or dextran, as a disperse phase and an organic solvent, e.g. a vegetable oil, slightly soluble in water as a dispersion medium, and polymerizing the above-mentioned alkyl 2-cyanoacrylate in the interface between the disperse phase and the dispersion medium to cover the disperse phase. The microencapsulated pharmaceutical is capable of enhancing the selectivity for tumorous tissues of the carcinostatic agent and controlling the releasing property of the drug effective component.
The purpose of this study is to carry out a field trial to evaluate the effectiveness of the b-SLIM digital Super Coach in a convenient sample of overweight and obese adults. The effectiveness will be evaluated at the individual level by means of a randomized trial. By combining or not combining the use of the b-SLIM digital Super Coach with a conventional physical activity and nutrition coaching, the effectiveness of the Super Coach of the (user-driven) 'Super Coach' compared to a conventional face to face weight loss program can be determined. Outcomes will be measured at the level of health behavior (i.e., physical activity and nutrition), body composition, physical fitness, psychosocial factors (e.g., motivation) and program adherence. The field trial will take place in Leuven (Belgium).

This study can be seen as a pilot trial. The central hypothesis of this field trial is that using the multi-source b-SLIM digital Super Coach will support and assist overweight and obese adults to change their health behavior (i.e., physical activity and nutrition) and to lose body weight by improving their self-control, self-determined motivation and attitude towards regular physical activity and healthy diet. The investigators will check if the Super Coach can be a valuable alternative for a conventional physical activity and nutrition coaching.